Breinholt MF, Schejbel L, Gang AO, Christensen IJ, et al. TP53 Mutation Is the Only Robust Mutational Biomarker for Outcome Found in a Consecutive Clinical Cohort of Real-Word Patients With Primary Large B-Cell Lymphoma. Eur J Haematol 2024 Dec 18. doi: 10.1111/ejh.14364.
PMID: 39691999